Carestream introduced its newly designed small-format CARESTREAM DRX Plus 2530C Detector with cesium iodide technology.

Until now, the $168 million facility was producing limited amounts of Mo-99, a radioisotope used in approximately 85% of all Australian nuclear medicine procedures such as SPECT scans.

Combining MRI and ultrasound (US) detected up to 33% more cancers than standard biopsy methods alone, according to new research published in JAMA Surgery.

Researchers from Boston University have developed a new magnetic metamaterial that could help improve the signal-to-noise ratio (SNR) of MRI scanners, sharing their findings in Communications Physics.

A team of German researchers has found a new class of radiopharmaceuticals capable of identifying 28 types of malignant tumors, imaging them with high uptake and image contrast.

Mammography clinics are getting creative these days in an effort  to make breast screening a little more appealing. Massage chairs and goody bags are only a few of the ways imaging providers are trying to make the experience more positive.

The U.S. Pharmacopeia (USP) recently published a new chapter outlining minimum standards for preparing, compounding, dispensing and packaging sterile and non-sterile radiopharmaceuticals that are part of state-licensed activities.

The American Society for Radiation Oncology (ASTRO) is championing bipartisan legislation introduced Wednesday, June 5, that would reduce prior authorization practices found to delay patient access to necessary cancer treatments.